Yoga practice can reduce metabolic syndrome and cardiovascular risk in climacteric women.
Cardiovascular risk
Climacteric
Menopause
Metabolic syndrome
Yoga
Journal
Journal of behavioral medicine
ISSN: 1573-3521
Titre abrégé: J Behav Med
Pays: United States
ID NLM: 7807105
Informations de publication
Date de publication:
09 Jun 2023
09 Jun 2023
Historique:
received:
28
07
2022
accepted:
20
03
2023
medline:
9
6
2023
pubmed:
9
6
2023
entrez:
9
6
2023
Statut:
aheadofprint
Résumé
To evaluate the effect of yoga on the frequency of MetS and its impact on cardiovascular risk markers in climacteric women. We recruited 84 sedentary women between 40 and 65 years diagnosed with MetS. Participants were randomly assigned to a 24-week yoga intervention or control group. We evaluated the frequency of MetS and changes in the individual components of MetS at baseline and after 24 weeks. We also assessed the impact of yoga practices on cardiovascular risk through the following markers: High-sensitivity C-reactive Protein (hs-CRP), Lipid Accumulation Product (LAP), Visceral Adiposity Index (VAI), and Atherogenic Index of Plasma (AIP). The frequency of MetS reduced significantly after 24 weeks of yoga practice (- 34.1%; p < 0.001). Statistical analysis showed that the frequency of MetS was significantly lower in the yoga group (65.9%; n = 27) than in the control group (93.0%; n = 40) after 24 weeks (p = 0.002). Regarding the individual components of MetS, yoga practitioners had statistically lower waist circumference, systolic blood pressure, triglycerides, HDLc, and glucose serum concentrations than the control group after 24 weeks. Yoga practitioners also had a significant decrease in hs-CRP serum concentrations (3.27 ± 2.95 mg/L vs. 2.52 ± 2.14 mg/L; p = 0.040) and a lower frequency of moderate or high cardiovascular risk (48.8% vs. 34.1%; p = 0.001) after 24 weeks of practice. The yoga group had LAP values significantly lower than the control group after the intervention period (55.8 ± 38.04 vs. 73.9 ± 40.7; p = 0.039). Yoga practice demonstrated to be an effective therapeutic to manage MetS and reduce cardiovascular risk in climacteric women.
Identifiants
pubmed: 37294473
doi: 10.1007/s10865-023-00420-y
pii: 10.1007/s10865-023-00420-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J. C., James, W. P. T., Loria, C. M., & Smith Jr, S. C. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation, 120, 1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
doi: 10.1161/CIRCULATIONAHA.109.192644
pubmed: 19805654
Alberti, K. G., Zimmet, P., & Shaw, J. (2006). Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabetic Medicine, 23, 469–480. https://doi.org/10.1111/j.1464-5491.2006.01858.x
doi: 10.1111/j.1464-5491.2006.01858.x
pubmed: 16681555
Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., & Group, A. S. (2010). Visceral adiposity index: A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care, 33, 920–922. https://doi.org/10.2337/dc09-1825
doi: 10.2337/dc09-1825
pubmed: 20067971
pmcid: 2845052
Anıkİlhan, G., & Yıldızhan, B. (2019). Visceral adiposity indicators as predictors of metabolic syndrome in postmenopausal women. Turkish Journal of Obstetriics Gynecology, 16, 164–168. https://doi.org/10.4274/tjod.galenos.2019.62558
doi: 10.4274/tjod.galenos.2019.62558
Chimkode, S. M., Kumaran, S. D., Kanhere, V. V., & Shivanna, R. (2015). Effect of yoga on blood glucose levels in patients with type 2 diabetes mellitus. Journal of Clinical and Diagnostic Research. https://doi.org/10.7860/JCDR/2015/12666.5744
doi: 10.7860/JCDR/2015/12666.5744
pubmed: 26023550
pmcid: 4437062
Cramer, H., Haller, H., Lauche, R., Steckhan, N., Michalsen, A., & Dobos, G. (2014a). A systematic review and meta-analysis of yoga for hypertension. American Journal of Hypertension, 27, 1146–1151. https://doi.org/10.1093/ajh/hpu078
doi: 10.1093/ajh/hpu078
pubmed: 24795403
Cramer, H., Langhorst, J., Dobos, G., & Lauche, R. (2016). Yoga for metabolic syndrome: A systematic review and meta-analysis. European Journal of Preventive Cardiology, 23, 1982–1993. https://doi.org/10.1177/2047487316665729
doi: 10.1177/2047487316665729
pubmed: 27550905
Cramer, H., Lauche, R., Haller, H., Steckhan, N., Michalsen, A., & Dobos, G. (2014b). Effects of yoga on cardiovascular disease risk factors: A systematic review and meta-analysis. International Journal of Cardiology, 173, 170–183. https://doi.org/10.1016/j.ijcard.2014.02.017
doi: 10.1016/j.ijcard.2014.02.017
pubmed: 24636547
Cramer, H., Sibbritt, D., Park, C. L., Adams, J., & Lauche, R. (2017). Is the practice of yoga or meditation associated with a healthy lifestyle? Results of a national cross-sectional survey of 28,695 Australian women. Journal of Psychosomatic Research, 101, 104–109. https://doi.org/10.1016/j.jpsychores.2017.07.013
doi: 10.1016/j.jpsychores.2017.07.013
pubmed: 28867414
de Siqueira Valadares, L. T., de Souza, L. S. B., Salgado Júnior, V. A., de Freitas Bonomo, L., de Macedo, L. R., & Silva, M. (2022). Prevalence of metabolic syndrome in Brazilian adults in the last 10 years: A systematic review and meta-analysis. BMC Public Health, 22, 327. https://doi.org/10.1186/s12889-022-12753-5
doi: 10.1186/s12889-022-12753-5
pubmed: 35172790
pmcid: 8848905
Dobiásová, M., & Frohlich, J. (2001). The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER (HDL)). Clinical Biochemistry, 34, 583–588.
doi: 10.1016/S0009-9120(01)00263-6
pubmed: 11738396
Dobrowolski, P., Prejbisz, A., Kuryłowicz, A., Baska, A., Burchardt, P., Chlebus, K., & Bogdański, P. (2022). Metabolic syndrome - a new definition and management guidelines: A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, "Club 30" Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons. Arch Med Sci, 18, 1133–1156. https://doi.org/10.5114/aoms/152921
Dutta, D., Bhattacharya, S., Sharma, M., Khandelwal, D., Surana, V., & Kalra, S. (2021). Effect of yoga on glycemia and lipid parameters in type-2 diabetes: A meta-analysis. Journal of Diabetes & Metabolic Disorders, 20, 349–367. https://doi.org/10.1007/s40200-021-00751-0
doi: 10.1007/s40200-021-00751-0
Fappa, E., Yannakoulia, M., Pitsavos, C., Skoumas, I., Valourdou, S., & Stefanadis, C. (2008). Lifestyle intervention in the management of metabolic syndrome: Could we improve adherence issues? Nutrition, 24, 286–291. https://doi.org/10.1016/j.nut.2007.11.008
doi: 10.1016/j.nut.2007.11.008
pubmed: 18201869
Ge, H., Yang, Z., Li, X., Liu, D., Li, Y., Pan, Y., & Wu, X. (2020). The prevalence and associated factors of metabolic syndrome in Chinese aging population. Scientific Reports, 10, 20034. https://doi.org/10.1038/s41598-020-77184-x
doi: 10.1038/s41598-020-77184-x
pubmed: 33208868
pmcid: 7675973
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., & Group, S. C. (2012). Executive summary of the stages of reproductive aging workshop +10: Addressing the unfinished agenda of staging reproductive aging. Climacteric, 15, 105–114. https://doi.org/10.3109/13697137.2011.650656
doi: 10.3109/13697137.2011.650656
pubmed: 22338612
pmcid: 3580996
Honour, J. W. (2018). Biochemistry of the menopause. Annals of Clinical Biochemistry, 55, 18–33. https://doi.org/10.1177/0004563217739930
doi: 10.1177/0004563217739930
pubmed: 29027807
Hsu, C. N., Hou, C. Y., Hsu, W. H., & Tain, Y. L. (2021). Early-life origins of metabolic syndrome: Mechanisms and preventive aspects. International Journal of Molecular Sciences, 22, 11872. https://doi.org/10.3390/ijms222111872
doi: 10.3390/ijms222111872
pubmed: 34769303
pmcid: 8584419
Innes, K. E., Selfe, T. K., & Taylor, A. G. (2008). Menopause, the metabolic syndrome, and mind-body therapies. Menopause, 15, 1005–1013. https://doi.org/10.1097/01.gme.0b013e318166904e
doi: 10.1097/01.gme.0b013e318166904e
pubmed: 18779682
pmcid: 2810543
Jeong, H. G., & Park, H. (2022). Metabolic disorders in menopause. Metabolites, 12, 954. https://doi.org/10.3390/metabo12100954
doi: 10.3390/metabo12100954
pubmed: 36295856
pmcid: 9606939
Jiang, X., Yang, Z., Wang, S., & Deng, S. (2022). “Big Data” approaches for prevention of the metabolic syndrome. Frontiers in Genetics, 13, 810152. https://doi.org/10.3389/fgene.2022.810152
doi: 10.3389/fgene.2022.810152
pubmed: 35571045
pmcid: 9095427
Kahn, H. S. (2005). The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison. BMC Cardiovascular Disorders, 5, 26. https://doi.org/10.1186/1471-2261-5-26
doi: 10.1186/1471-2261-5-26
pubmed: 16150143
pmcid: 1236917
Kahn, R., Buse, J., Ferrannini, E., Stern, M., Association, A. D., & Diabetes, E. A. (2005). The metabolic syndrome: Time for a critical appraisal: Joint statement from the American diabetes association and the European association for the study of diabetes. Diabetes Care, 28, 2289–2304. https://doi.org/10.2337/diacare.28.9.2289
doi: 10.2337/diacare.28.9.2289
pubmed: 16123508
Khoshnaw, D. M., & Ghadge, A. A. (2021). Yoga as a complementary therapy for metabolic syndrome: A narrative review. Journal of Integrative Medicine, 19, 6–12. https://doi.org/10.1016/j.joim.2020.09.002
doi: 10.1016/j.joim.2020.09.002
pubmed: 32952098
Lau, C., Yu, R., & Woo, J. (2015). Effects of a 12-week hatha yoga intervention on metabolic risk and quality of life in Hong Kong Chinese adults with and without metabolic syndrome. PLoS ONE, 10, e0130731. https://doi.org/10.1371/journal.pone.0130731
doi: 10.1371/journal.pone.0130731
pubmed: 26111165
pmcid: 4482438
Lee, J. A., Kim, J. W., & Kim, D. Y. (2012). Effects of yoga exercise on serum adiponectin and metabolic syndrome factors in obese postmenopausal women. Menopause, 19, 296–301. https://doi.org/10.1097/gme.0b013e31822d59a2
doi: 10.1097/gme.0b013e31822d59a2
pubmed: 22089179
Li, Y., Zhao, D., Wang, M., Sun, J. Y., Liu, J., Qi, Y., & Liu, M. (2021). Combined effect of menopause and cardiovascular risk factors on death and cardiovascular disease: A cohort study. BMC Cardiovascular Disorders, 21, 109. https://doi.org/10.1186/s12872-021-01919-5
doi: 10.1186/s12872-021-01919-5
pubmed: 33622241
pmcid: 7903751
Li, Y., Zhong, X., Cheng, G., Zhao, C., Zhang, L., Hong, Y., & Wang, Z. (2017). Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. Atherosclerosis, 259, 75–82. https://doi.org/10.1016/j.atherosclerosis.2017.02.003
doi: 10.1016/j.atherosclerosis.2017.02.003
pubmed: 28327451
Lyngbakken, M. N., Myhre, P. L., Røsjø, H., & Omland, T. (2019). Novel biomarkers of cardiovascular disease: Applications in clinical practice. Critical Reviews in Clinical Laboratory Sciences, 56, 33–60. https://doi.org/10.1080/10408363.2018.1525335
doi: 10.1080/10408363.2018.1525335
pubmed: 30457415
Moore, J. X., Chaudhary, N., & Akinyemiju, T. (2017). Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National health and nutrition examination survey, 1988–2012. Preventing Chronic Disease, 14, E24. https://doi.org/10.5888/pcd14.160287
doi: 10.5888/pcd14.160287
pubmed: 28301314
pmcid: 5364735
Oladejo, A. O. (2011). Overview of the metabolic syndrome; an emerging pandemic of public health significance. Annals of Ibadan Postgraduate Medicine, 9, 78–82.
pubmed: 25161488
pmcid: 4111026
Pu, D., Tan, R., Yu, Q., & Wu, J. (2017). Metabolic syndrome in menopause and associated factors: A meta-analysis. Climacteric, 20, 583–591. https://doi.org/10.1080/13697137.2017.1386649
doi: 10.1080/13697137.2017.1386649
pubmed: 29064321
Raveendran, A. V., Deshpandae, A., & Joshi, S. R. (2018). Therapeutic role of yoga in type 2 diabetes. Endocrinology and Metabolism (seoul), 33, 307–317. https://doi.org/10.3803/EnM.2018.33.3.307
doi: 10.3803/EnM.2018.33.3.307
Shantakumari, N., & Sequeira, S. (2013). Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia. Indian Heart Journal, 65, 127–131. https://doi.org/10.1016/j.ihj.2013.02.010
doi: 10.1016/j.ihj.2013.02.010
pubmed: 23647889
pmcid: 3861018
Shobana, R., Maheshkumar, K., Venkateswaran, S. T., Geetha, M. B., & Padmavathi, R. (2022). Effect of long-term yoga training on autonomic function among the healthy adults. Journal of Family Medicine and Primary Care, 11, 3471–3475. https://doi.org/10.4103/jfmpc.jfmpc_199_21
doi: 10.4103/jfmpc.jfmpc_199_21
pubmed: 36387716
pmcid: 9648241
Siqueira-Batista, R. (2015). Shivam Yoga and health promotion. Revista Ciências e Ideias, 6, 157–160.
Siu, P. M., Yu, A. P., Benzie, I. F., & Woo, J. (2015). Effects of 1-year yoga on cardiovascular risk factors in middle-aged and older adults with metabolic syndrome: A randomized trial. Diabetology & Metabolic Syndrome, 7, 40. https://doi.org/10.1186/s13098-015-0034-3
doi: 10.1186/s13098-015-0034-3
Souza, L. A. C., & Lima, A. A. (2021). Anthropometric, biochemical and clinical parameters in climacteric yoga practitioners. Climacteric. https://doi.org/10.1080/13697137.2021.1965115
doi: 10.1080/13697137.2021.1965115
pubmed: 34423699
Stefanska, A., Bergmann, K., & Sypniewska, G. (2015). Metabolic syndrome and menopause: Pathophysiology, clinical and diagnostic significance. Advances in Clinical Chemistry, 72, 1–75. https://doi.org/10.1016/bs.acc.2015.07.001
doi: 10.1016/bs.acc.2015.07.001
pubmed: 26471080
Stephens, I. (2017). Medical yoga therapy. Children (basel). https://doi.org/10.3390/children4020012
doi: 10.3390/children4020012
pubmed: 28208599
Sternfeld, B., Wang, H., Quesenberry, C. P., Abrams, B., Everson-Rose, S. A., Greendale, G. A., & Sowers, M. (2004). Physical activity and changes in weight and waist circumference in midlife women: Findings from the study of women’s health across the nation. American Journal of Epidemiology, 160, 912–922. https://doi.org/10.1093/aje/kwh299
doi: 10.1093/aje/kwh299
pubmed: 15496544
Vempati, R. P., & Telles, S. (2002). Yoga-based guided relaxation reduces sympathetic activity judged from baseline levels. Psychological Reports, 90, 487–494. https://doi.org/10.2466/pr0.2002.90.2.487
doi: 10.2466/pr0.2002.90.2.487
pubmed: 12061588
Wang, H. H., Lee, D. K., Liu, M., Portincasa, P., & Wang, D. Q. (2020). Novel insights into the pathogenesis and management of the metabolic syndrome. Pediatric Gastroenterology Hepatology & Nutrition, 23, 189–230. https://doi.org/10.5223/pghn.2020.23.3.189
doi: 10.5223/pghn.2020.23.3.189
Wu, T. T., Gao, Y., Zheng, Y. Y., Ma, Y. T., & Xie, X. (2018). Atherogenic index of plasma (AIP): A novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids in Health and Disease, 17, 197. https://doi.org/10.1186/s12944-018-0828-z
doi: 10.1186/s12944-018-0828-z
pubmed: 30134981
pmcid: 6106932